The only director selling that has had any notable impact on price was that of JC post CPACS raise (when he was our Chairman, no less). As ex-directors, JC and BG have only ever been 10-15% of free float volume. That free float surged due to RAC incurred clinical delays (some strategic, some not).
The SP has reflected broader holder movements, not that of ex-directors. There was a ~30% collapse in SP in the 2 months AFTER BG ceased selling.
Anyway, I look forward to updating this chart when the next 4C is released. We're already seeing a stark improvement in both shareholders, and share price, all the while JC is selling!
Ann: Race In-person Investor Briefing Invitation Perth, page-47
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.050(3.33%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.55 | $1.49 | $86.32K | 57.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4520 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 2259 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |